JPMorgan analyst Tomohiko Sano lowered the firm’s price target on Mirion (MIR) to $30 from $33 and keeps an Overweight rating on the shares. The firm says that as macro uncertainty persists, “disciplined leaders” in the smaller cap industrial space remain well positioned for long-term growth. It adjusted price targets as part of a mid-quarter recap.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on MIR:
- Mirion Technologies: Solid Nuclear and Medical Demand, Improving Margins, and Paragon Synergies Support Buy Rating and Mid-30% Upside Potential
- Omega takes new stake in Rocket Companies, exits ArriVent Biopharma
- Mirion Technologies Signals Confident Path to 2026
- Mirion price target lowered to $29 from $30 at Baird
- Mirion price target lowered to $29 from $33 at Goldman Sachs, says buy the dip